Inhibitors, such as JQ1 and I-BET, targeting BET proteins compete with... | Download Scientific Diagram
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer | Nature
The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors - eBioMedicine
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
JQ1 - Wikipedia
JQ1 inhibits the proliferation, migration, and invasion of gastric... | Download Scientific Diagram
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases - Kulikowski - 2021 - Medicinal Research Reviews - Wiley Online Library
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer - ScienceDirect
Frontiers | Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
JQ1 treatment of human luminal breast cancer cell lines reduces cell... | Download Scientific Diagram
JCI - Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1
The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner | Bentham Science
Repression of BET activity sensitizes homologous recombination–proficient cancers to PARP inhibition | Science Translational Medicine
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
Cancers | Free Full-Text | The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer | HTML
Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections | PNAS
BET inhibition induces an anti-apoptotic adaptive response and therapeutic vulnerability to MCL1 inhibitors in breast cancer | bioRxiv
Achieving clinical success with BET inhibitors as anti-cancer agents | British Journal of Cancer
Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4 | Oncogenesis
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML | Oncogene
Predicting response to BET inhibitors using computational modeling: A BEAT AML project study - ScienceDirect
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
